ABSTRACT
Objective Death data from cohorts of academicians have been used to estimate pandemic excess deaths. We aimed to evaluate the validity of this approach.
Study design and setting Data were analyzed from living and deceased member lists from Mainland China, UK and Greece academies; and Nobel laureates (and US subset thereof). Samples of early elected academicians were probed for unrecorded deaths; datasets overtly missing deaths were excluded from further analyses. Actuarial risks were compared against the general population in the same country in respective age strata. Relative incidence risk increases in death in active pandemic periods were compared to population-wide pandemic excess death estimates for the same country.
Results Royal Society and Academy of Athens datasets overtly missed deaths. Pre-pandemic death rates were 4-12-fold lower in the Chinese Academy of Engineering (CAE) versus respective age strata of the Mainland China population. A +158% relative increase in death risk was seen in CAE data during the first 12-months of wide viral spread. Both increases (+34% in British Academy) and decreases (-27% in US Nobel laureates) in death rates occurred in pandemic (2020-22) versus pre-pandemic (2017-2019) years; point estimates were far from known excess deaths in the respective countries (+6% and +14%, respectively). Published excess death estimates for urban-dwelling Mainland China selectively analyzed CAE, but not another Chinese academy (Chinese Academy of Sciences) with half the pandemic death rates.
Conclusion Missingness, lack of representativeness, large uncertainty, and selective analysis reporting make data from academy rosters unreliable for estimating general population excess deaths.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The work of JPAI is supported by an unrestricted gift from Sue and Bob O Donnell to Stanford University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Funding: The work of JPAI is supported by an unrestricted gift from Sue and Bob O’ Donnell to Stanford University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Data sharing: All key data are in the manuscript and in databases that are already open to the public.
Conflicts of interest: None.
Data Availability
All key data are in the manuscript and in databases that are already open to the public.
